SAN DIEGO, March 9, 2023 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced it will present data from three in vitro dissolution studies exploring the dissolution performance ...
Over 141,000 bottles of cholesterol medication have been recalled due to “failed dissolution specifications,” suggesting that the drugs did not pass a solubility test, or failed to dissolve at a ...
The FDA released an announcement for a voluntary national recall of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K on Tuesday, June 25th. Glenmark Pharmaceuticals Inc., USA, ...
(RTTNews) - Mahwah, New Jersey-based Glenmark Pharmaceuticals Inc., USA is recalling 114 batches of Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEq K citing failed dissolution, ...
At this time, there have been no reports of injury related to this recall. Glenmark Pharmaceuticals is recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750mg) 10 mEq K due ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results